World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 February 2023
Main ID:  NCT02967640
Date of registration: 16/11/2016
Prospective Registration: Yes
Primary sponsor: Helse Møre og Romsdal HF
Public title: Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?
Scientific title: Does Subacromial Injection With Glutamate Receptor (NMDAR) Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?
Date of first enrolment: May 1, 2018
Target sample size: 20
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02967640
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).  
Phase:  Phase 2/Phase 3
Countries of recruitment
Norway
Contacts
Name:     Ola M Lian, md
Address: 
Telephone: +47 272847
Email: Ola.Midtsether.Lian@helse-mr.no
Affiliation: 
Name:     Ola M Lian, MD
Address: 
Telephone:
Email: Ola.Midtsether.Lian@helse-mr.no
Affiliation: 
Name:     Oystein B Lian, md phd
Address: 
Telephone:
Email:
Affiliation:  Helse Nord-Trøndelag HF
Key inclusion & exclusion criteria

Inclusion Criteria:

- diagnosis of rotator cuff tendinopathy by exercise-related shoulder pain with positive
impingement tests as described by Hawkins and Neers, and MRI findings consistent with
tendinopathy.

- Symptom duration at least 1 year to ensure neuronal ingrowth and NMDAR expression

Exclusion Criteria:

- previous surgery in any shoulder.

- previous cortisone use, either as injections or orally

- symptoms or signs of cervicobrachialgia or polyneuropathy

- full thickness rotator cuff ruptures verified by MRI

- primary inflammatory mediated pain, hence, patients with glenohumeral arthrosis,
glenohumeral arthritis or systemic disorders predisposing for arthritis

- a central component of pain perception manifested by radiating pain in the involved
limb; implying worse outcome after subacromial decompression.

- pregnancy

- breastfeeding

- reduced liver function (Increased serum bilirubin, ASAT or ALAT), decompensated heart
failure (NYHA class 3-4)

- increased intracranial pressure or disease of the central nervous system (CNS)

- chronic alcoholism

- epilepsy

- psychiatric disease, increased intraocular pressure

- acute intermittent porphyria

- hyperthyroidism

- use of thyroid hormones

- upper respiratory tract infections

- pneumonia

- intracranial lesions

- acute head injuries

- ocular injuries

- hydrocephalus

- risk factors predisposing for intra-articular bleeding

- increased risk of infection



Age minimum: 40 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Rotator Cuff Tendinitis
Chronic Pain
Intervention(s)
Drug: Ketalar
Drug: NaCl 9%
Primary Outcome(s)
Supraspinatus pressure pain threshold [Time Frame: 30 minutes]
Secondary Outcome(s)
Western Ontario Rotator Cuff Index [Time Frame: 30 minutes]
Pain [Time Frame: 30 minutes]
Oxford Shoulder Score [Time Frame: 30 minutes]
Pressure pain tolerance [Time Frame: 30 minutes]
Secondary ID(s)
2012/1199
2012-002782-35
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history